Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics ...
On Oct. 6, more than 51,000 teachers across Alberta walked off the job after months of failed negotiations between the Alberta Teachers’ Association and the provincial government. Key issues the two ...
GV- and Arch-backed Pelage Pharma is developing a first-of-its-kind topical stem-cell therapy that could redefine the $10B ...
Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Confirmed responses observed in eight tumor types spanning ova ...
Cervical cancer, one of the most preventable yet lethal malignancies among women, continues to threaten lives globally due to ...
Superintendent Anita Huggins praised the Charleston County Schools for their academic gains and historic achievements, ...
Superintendent Anita Huggins praised Charleston County Schools for their academic gains and historic achievements, ...
Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 ...
Vietnam Investment Review on MSN
CStone CS2009 ESMO 2025 Trispecific Antibody Phase I Data Disclosed
CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key ...
MedPage Today on MSN
A Hit and a Miss for Liquid Biopsy to Guide Adjuvant Cancer Therapy
Median disease-free survival (DFS) increased from 4.8 months with placebo to 9.9 months with adjuvant atezolizumab (Tecentriq ...
Palestinian militants have so far released 15 bodies of hostages that were held in Gaza for the past two years as part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results